| 000 | 00930nam a2200181Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625122511.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-6091 | ||
| 245 | 1 | 0 | _aUse of structural information in drug design |
| 490 | 0 | _vCurrent Opinion in Structural Biology, 2(2), p.202-210, 1992 | |
| 520 | 3 | _aModern drug design increasingly relies on structural information for the improvement of in vitro potency. Recently, these methods have been used to optimize in vitro properties as well. Barries to the sucessful integration of these technologies within the drug industry seem to be largely cultural rather than scientific. | |
| 700 | 1 | 2 | _aNavia, M.A. |
| 700 | 1 | 2 | _aMurcko, M.A. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1EHdQSxHY-9nQ0I0r9brBIIpz2gFOZcwo/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c40436 _d40436 |
||